Immunotherapy in Multiple Myeloma
| Autor: | Donna Catamero, Charise Gleason |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.drug_class
medicine.medical_treatment Monoclonal antibody 03 medical and health sciences 0302 clinical medicine Humans Medicine Elotuzumab Nursing management Multiple myeloma Nursing practice Oncology (nursing) business.industry Antibodies Monoclonal Treatment options Daratumumab Immunotherapy medicine.disease Treatment Outcome 030220 oncology & carcinogenesis Immunology Multiple Myeloma business 030215 immunology medicine.drug |
| Zdroj: | Seminars in Oncology Nursing. 33:292-298 |
| ISSN: | 0749-2081 |
| Popis: | Objectives To review the use of monoclonal antibodies (mAbs) in the treatment of multiple myeloma (MM) and the management of most common side effects. Data Sources Review of journal articles related to mAbs in MM. Conclusion The therapeutic options for MM have improved dramatically and the development of mAbs has been associated with improvement in clinical outcomes and favorable toxicity profiles. Implications for Nursing Practice With appropriate pre-medications and nursing management, mAbs are a well-tolerated treatment option for myeloma patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect